Clinical Trial Update: Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer

View source ↗

Summary

This clinical trial update discusses the side effects observed with anti-PD-1/PD-L1 and anti-CTLA-4 therapies in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Carcinoma, Non-Small-Cell Lung, Drug-Related Side Effects and Adverse Reactions | Status: COMPLETED